What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths. Type 2 diabetes mellitus has been associated with HCC. However, the relationship between type 2 diabetes mellitus and the underlying liver cirrhosis, and the effects o...Future for radioembolisation in patients with advanced hepatocellular carcinoma
Copenhagen, Denmark, Friday 24 April: Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC portal vein thrombosis, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the...New oncogene gives valuable insight into hepatocellular tumors in humans
Copenhagen, Denmark, Thursday 23 April: The first identification of GP130 somatic activating mutations* in human tumours was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver Disease in Copenhagen, Denmark. Identification of recurrent somatic m...Liver cell adenoma or hepatocellular carcinoma?
Recently, LCAs with typical backgrounds of the patients are diagnosed by radiological findings without pathological findings due to the progress of diagnostic imaging techniques. A typical LCA shows low density or isodensity on plain computed tomography, presents a homogenous contrasting effect on...A useful imaging modality for monitoring treatment response to hepatocellular carcinoma
TACE has been widely accepted as a choice of treatment for advanced HCC. CT perfusion is a non-invasive and reproducible technique for assessing perfusion changes due to TACE therapy for locally advanced HCC. However, there are few reports on the application of this technique in evaluating the eff...How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma?
Many hepatocellular carcinoma (HCC) patients in China may be treated with Traditional Chinese medicine (TCM). Some say it works, others doubt its effectiveness. These stated that a research group in China had found TCM can down-regulate the expression of PTEN in HCC, which may suppress tumor cell ...A new chemotherapeutic target for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a major health problem worldwide. Currently, the only chance for obtaining a cure in patients with HCC is by either a surgical resection or liver transplantation. However, many HCCs with scattered tumors cannot be operated on. In such patients, effective alternati...Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
Portal venous tumor thrombus (PVTT) is a crucial factor that can worsen the prognosis of patients with hepatocellular carcinoma (HCC). It often leads to extensive spreading of the tumor throughout the liver, and can increase portal venous blood pressure, resulting in the fatal rupture of esophagea...A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
Traditional Chinese medicine is world renowned. It has supernatural effects on some diseases, but the reason is still unknown. One such article was recently reported in the November 7 issue of the World Journal of Gastroenterology dealing with the great significance of a Chinese medicinal compound...Is RTA a new potential option for the treatment of hydatid cysts?
...laced in an organ tissue into released heat, which then causes tissue necrosis. This technique is currently used for treatment of neoplasms, primarily hepatocellular carcinoma. The authors wanted to verify whether radiofrequency is able to warm and irreversibly damage hydatid cysts, causing cyst wall necrosis t...Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
Genomics improves our ability to target experimental cancer treatments A promising new drug is in hand, and more are on the way Improved ability to select patients to test particular drugs MILAN, Italy, April 27 /PRNewswire/ -- At today's sessions of this, the final day of the 4...Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
...reventing tumor progression, as measured by modified RECIST criteria at eight weeks from initiation of treatment in patients with unresectable primary hepatocellular carcinoma. In addition, safety and tolerability, as well as tumor response and progression-free survival, of JX-594 administered at the two dose level...Genetically engineered mice yield clues to 'knocking out' cancer
...This indicates that there was a lack of DNA repair in these organs. During the second year of life, both types of mice also developed pulmonary and hepatocellular (liver cell) tumors. Double knockout mice had a higher incidence of tumors than the single knockouts. The researchers state that their results emph...Society of Interventional Radiology Foundation awards $191,000 in grants
...ative MR Perfusion Parameters With Pathology Following Chemoembolization of hepatocellular Carcinoma (HCC)," and Brian Jin, "The Correlation of Angiographic Endpoints With Perfusion and Clinical Outcomes During Chemoembolization of hepatocellular Carcinoma," both at Northwestern University, Chicago, Ill."; Lydia Kuo, ...Researchers identify gene linked to aggressive progression of liver cancer
...lating liver cancer progression, a discovery that could one day lead to new targeted therapeutic strategies to fight the highly aggressive disease. hepatocellular carcinoma, HCC, or liver cancer, is the fifth most common cancer and the third leading cause of cancer deaths in the world. Treatment options for HCC ...Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage
...xperiments conducted by the same CSHL team last year linking senescence in liver cells with the organ's ability to fight off liver cancer, also called hepatocellular carcinoma, or HCC. The new findings are the first to establish a specific role for cellular senescence in a non-cancer pathology, and, the CSHL t...Gene variation may elevate risk of liver tumor in patients with cirrhosis
... A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death. In the January 2 Journal of the American Medical Association, researc...Story ideas from Molecular & Cellular Proteomics
...ins that could be used to improve the diagnosis of hepatocellular carcinoma, the most common type of liver cancer. hepatocellular carcinoma causes about one million deaths each yea...are either increased or decreased in patients with hepatocellular carcinoma. Among the many proteins they found, two...Targeting nerve growth factor may cure liver cancer
...ohistology, these scientists showed that NGF and its receptor trkANGF were expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma (HCC) while these two molecules are not detected in the liver of healthy people. For a growth factor to affect a cell, there should be its s...Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
...with a more than 200-fold increase in risk of liver cancer. In areas where HBV is endemic, like China and the Far East, the great majority of cases of hepatocellular carcinoma (HCC) occur in individuals with the virus. For most patients whose cancer is inoperable, chemotherapy is one of the main treatment options, ...Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer
...hepatitis B and C virus infections. Since most hepatocellular or liver carcinomas (HCC) are diagnosed at an adva...or on the research. “Having the tools to identify hepatocellular carcinoma at earlier stages, is truly a breakthrou...ut what this means in terms of early detection for hepatocellular cancer but optimistic about how it could also be a...New culture method for hepatitis C virus uses primary hepatocytes and patient serum
... C virus (HCV) infection affects approximately 170,000,000 people worldwide. HCV liver disease, which may induce liver inflammation, cirrhosis, and/or hepatocellular carcinoma, represents the foremost reason for liver transplantation in much of the U.S. Study of HCV replication within liver cells, or hepatocyt...Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
...ial data from this study in 2009. The results of the NSCLC trial, along with the results of ongoing randomized Phase 2 studies of HGS-ETR1 in advanced hepatocellular cancer and advanced multiple myeloma, will support a decision on whether to advance HGS-ETR1 to Phase 3 development. A sufficiently positive result fr...Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
...pletion of Randomization in HGS-ETR1 NSCLC Trial Expected Shortly; HGS-ETR1 hepatocellular Cancer Trial and First Clinical Trial of HGS1029 Initiated Three randomiz... HGS-ETR1 in combination with Nexavar (sorafenib) in patients with advanced hepatocellular cancer (HCC), which accounts for 80- 90% of all liver cancers. The Company ...FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
... is approved for use in patients with unresectable hepatocellular carcinoma (HCC). EOVIST is marketed by Bayer Hea...ere characterized as one of the following choices: hepatocellular carcinoma, cholangiocarcinoma, metastasis, focal l...rt for the treatment of patients with unresectable hepatocellular carcinoma, hypertension may occur early in the cou...Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
...rial of HGS-ETR1 by mid-2008 in patients with hepatocellular cancer, which accounts for 80-90% of all liver cancers. Preclinical data that support the hepatocellular cancer study were presented at the American Association for Cancer Research annual meeting in April. Darapladib Advanced by GSK to Phase 3 Developme...Liver Diseases: A Huge European Health Burden, But Some Trends are Positive
...r, or when damage precludes sufficient liver function, a liver transplant becomes necessary. Cirrhosis is the major risk factor for the development of hepatocellular carcinoma (HCC), a primary cancer of liver cells, which may also require transplantation. Estimates suggest 10 million carriers of viral hepatitis i...Human Genome Sciences Advances Oncology Portfolio
...ion trial of HGS-ETR1 by mid-2008 in patients with hepatocellular cancer. (Logo: http://www.newscom.com/cgi-bin/p...TR1 in combination with Nexavar (sorafenib) in hepatocellular cancer. The study in hepatocellular cancer will begin with a safety lead-in to ass...Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
...otably, he led the team that discovered and advanced Nexavar(R) (sorafenib), an anti-cancer agent that is approved for indications including renal and hepatocellular cancer, with Phase III studies underway in non-small-cell lung and other cancers. Later, as the VP and Department Head of Chemistry Research in West H...Hep G2 cell line slides ( human: liver; hepatocellular carcinoma ) from GeneTex
Description: Human Hep G2 cells were cultured in Minimum Essential Medium (Eagle) with 2 mM L-glutamine and harvested at the log phase of growth. In order to keep the antigens in their native forms, cells were fixed in acetone-methanol. The cells are arrayed on a 12-well (5 mm) adhesive coated slide, with eac...